- Invest in life sciences, longevity, neurodegeneration, and breakthrough therapeutics
- Are family offices or private investors actively deploying
- Want exposure to de-risked IP with potentially shorter paths to liquidity
- Prefer direct co-investment opportunities over a purely blind-pool model
- Are looking beyond traditional “2 and 20” venture structures
- Are strategic or corporate investors seeking emerging life sciences assets
By attending the Event, you acknowledge and agree that photographs, video, and other recordings may be taken during the event. These materials may be used by the Company for promotional, marketing, and business purposes across various media channels without additional compensation.
By registering, you also consent to your registration details, including your email address, being shared with the event partner(s) for purposes related to the Event.